HIS
CDTX

Harvest Investment Services’s Cidara Therapeutics CDTX Stock Holding History

Harvest Investment Services’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,045
Closed -$3.1M – 355
2025
Q4 		$3.1M Buy
14,045
+6,173
+78% +$998K 0.59% 48
2025
Q3 		$754K Buy
+7,872
New +$502K 0.15% 151

Harvest Investment Services's CDTX Position: Q1 2026 in Review

Harvest Investment Services sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 14,045 shares — an estimated $3.1M sold.

Harvest Investment Services first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.1M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Harvest Investment Services reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Harvest Investment Services sold 14,045 Cidara Therapeutics shares in Q1 2026, an estimated $3.1M.
  • Harvest Investment Services first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
  • Harvest Investment Services's Cidara Therapeutics position peaked at $3.1M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Harvest Investment Services's 13F filing for Q1 2026, filed 15 May 2026.